Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements | 58 | PR Newswire | Leveraging the Company's System-on-a-Chip (SoC), the clinical study results are another significant step forward in commercializing a cuffless, radio frequency (RF)-enabled blood pressure... ► Artikel lesen | |
09.04. | Movano Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
04.02. | Movano Health kicks off cuffless blood pressure device study | 2 | MassDevice | ||
02.01. | Movano Inc. - 8-K, Current Report | 1 | SEC Filings | ||
02.01. | Movano Health expands board with healthcare investment expert | 2 | Investing.com | ||
02.01. | Movano Health erweitert Vorstand um Experten für Gesundheitsinvestitionen | 2 | Investing.com Deutsch | ||
02.12.24 | FDA clears Movano smart ring's pulse oximetry feature | 1 | MassDevice | ||
02.12.24 | Movano Health Receives FDA Clearance for EvieMED Ring | 155 | PR Newswire | Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunities PLEASANTON, Calif., Dec. 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer... ► Artikel lesen | |
MOVANO Aktie jetzt für 0€ handeln | |||||
15.11.24 | Movano Inc. (NASDAQ:MOVE) Q3 2024 Earnings Call Transcript | 3 | Insider Monkey | ||
14.11.24 | Movano Health Reports Q3 2024 Financial Results and Provides Business Update | 116 | PR Newswire | Highlights successful Evie Ring back-in-stock execution
Updates status of EvieMED 510(k) application review
Focuses on launch of EvieMED and securing B2B opportunities... ► Artikel lesen | |
13.11.24 | Movano's Earnings: A Preview | 1 | Benzinga.com | ||
07.11.24 | Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device | 120 | PR Newswire | New hardware boasts significant improvements to reduce noise and generate higher fidelity signals
PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Movano Health... ► Artikel lesen | |
04.11.24 | Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED | 124 | PR Newswire | Company remains optimistic on the potential for this pioneering healthcare solution
PLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ: MOVE)... ► Artikel lesen | |
04.11.24 | Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split | 138 | PR Newswire | Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders
PLEASANTON, Calif., Nov. 4, 2024... ► Artikel lesen | |
31.10.24 | Movano Health probes stock manipulation after reverse split | 1 | Investing.com | ||
31.10.24 | Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split | 108 | PR Newswire | Company Communicating with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders
PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/... ► Artikel lesen | |
25.10.24 | Movano Health Announces Reverse Stock Split | 179 | PR Newswire | Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024
PLEASANTON, Calif., Oct. 25, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)... ► Artikel lesen | |
24.10.24 | Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase | 104 | PR Newswire | A successful response to requests for additional information would bring the Company one step closer to introducing this pioneering healthcare product to the market
PLEASANTON, Calif., Oct. 24,... ► Artikel lesen | |
10.10.24 | Movano Health Provides Update on FDA Review of EvieMED Ring | 152 | PR Newswire | The Company continues to work closely with the FDA to bring this pioneering healthcare product to market
PLEASANTON, Calif., Oct. 10, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced... ► Artikel lesen | |
14.08.24 | Movano Health Reports Q2 2024 Financial Results and Provides Business Update | 223 | PR Newswire | Prepares for September 17, 2024, Evie Ring back in stock dateAnnounces brand partnership with digital creator Heidi D'AmelioFocuses on launch of EvieMED and securing B2B opportunitiesConference Call... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PROCEPT BIOROBOTICS | 52,56 | 0,00 % | PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops | ||
BRIGHTSPRING HEALTH SERVICES | 16,550 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 18,040 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance | Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,460 | +1,26 % | EQS-DD: Siemens Healthineers AG: Darleen Caron, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
22.04.2025 / 17:45... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 6,490 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2024 Results | SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
FRESENIUS | 39,880 | +0,08 % | BARCLAYS stuft Fresenius SE auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Fresenius von 44,00 auf 43,50 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Die Bad Homburger dürften... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,980 | +1,25 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 42,50 auf 40,50 Euro gesenkt, aber die Einstufung auf "Equal Weight" belassen. Die schwere Grippewelle... ► Artikel lesen | |
NUTEX HEALTH | 140,51 | 0,00 % | Nutex Health Inc. (NUTX): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout | ||
GENEDX | 109,22 | 0,00 % | GeneDx To Buy Fabric Genomics | ||
GERRESHEIMER | 54,30 | +1,31 % | EQS-HV: Gerresheimer AG: Bekanntmachung der Einberufung zur Hauptversammlung am 05.06.2025 in Düsseldorf mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: Gerresheimer AG
/ Bekanntmachung der Einberufung zur Hauptversammlung
Gerresheimer AG: Bekanntmachung der Einberufung zur Hauptversammlung am 05.06.2025 in Düsseldorf... ► Artikel lesen | |
RXSIGHT | 14,730 | 0,00 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
UNITEDHEALTH | 374,95 | +0,56 % | UnitedHealth-Aktie -23%: Jetzt zuschlagen? | Mit einem gewaltigen Kurseinbruch von -23% sorgte die UnitedHealth-Aktie für große Kopfschmerzen bei ihren Anlegern und war damit der ganz große Verlierer am gestrigen Handelstag unter den großen US-Werten.... ► Artikel lesen | |
CARL ZEISS MEDITEC | 58,30 | -0,77 % | Hat Carl Zeiss Meditec die Digitalisierung der Augenheilkunde in der Hand? | Der Jenaer Medizintechnikkonzern Carl Zeiss Meditec AG (DE0005313704) feiert einen beachtlichen Meilenstein im US-Markt: Mehr als zwei Millionen Kataraktoperationen wurden inzwischen mit dem digitalen... ► Artikel lesen | |
DOCGO | 2,220 | 0,00 % | Pre-market Movers: Interactive Strength, DocGo, DLocal, Iovance Biotherapeutics, Acadia Healthcare | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.00 A.M. ET).In the Green Interactive Strength Inc. (TRNR) is up over 30% at... ► Artikel lesen | |
THERMO FISHER | 377,00 | +0,59 % | Geschäftszahlen veröffentlicht: Thermo Fisher überrascht mit starken Zahlen - Aktie vor Kurssprung? | © Foto: © Copyright 2024 Thermo Fisher ScientificDer US-Wissenschaftsdienstleister Thermo Fisher hat Einblick in seine Geschäftsbücher gegeben.Thermo Fisher Scientific, der weltweit führende Wissenschaftsdienstleister... ► Artikel lesen |